link: http://ift.tt/1jaUDvL
Hot And Trending...
Trending
- SRSrocco put together a graph tracking production for the top-four gold producers. You will note a pretty consistent downward trend. If these forecasts hold, we are looking at a 23% drop in output over less than a decade. http://bit.ly/2I5FJVb http://bit.ly/2D3w91e
- Gallup's U.S. Economic Confidence Index averaged -12 in July, down from - 8 in June, hitting its lowest average since Oct. 2014.
- @Macrotots Yep, Its the what have you done for me lately mentality. Also Dems will argue Obama deficits were necessary to get us out of recession, but that Trump deficits caused problems as the economy was growing when they were run up.
- It took a lot of chutzpah for Pres. Obama to double the national debt, then in his #SOTU address take credit for having reduced the deficit!
- South Koreans On Track to Buy Record Amount of Physical Gold @SchiffGold http://bit.ly/1VZFUmr
- US Markets “Feel Sick” After Bernanke/Krugman Bet on Bull @SchiffGold http://bit.ly/1UbvT1W
- I believe that this year, the dollar is going to hit an all-time record low. I think we’re going to crack below 6-to-1 in yuan. http://bit.ly/2of79zv
- Silver had a tough year in 2017, with flat demand and shrinking supply. Yet investors still received a nice 6% increase on their investments. http://bit.ly/2CFzTts
- CEO who raised price of drug by 5000%
- #JanetYellen provides that you can love economics, study it at the best universities, make it your career, yet still not understand it!
Wednesday, September 23, 2015
CEO who raised price of drug by 5000%
I know everyone is hating on this guy, but here is my view on the whole thing. So yeah this guy may be a prick, but from purely an economic sense, what he did might not be so terrible. The patent that Turing Pharmaceuticals purchased is for Daraprim, and from what I know, the patent is actually expired, all he bought was the right to sell the branded drug. No one is producing it generically - yet. With the massive price hike surely some pharmaceutical companies will come in with generic versions of Daraprim and undercut Turing's prices and increase supply until there is competitive equilibrium. What do you think?